![](/img/cover-not-exists.png)
625PDPembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study
Ueno, M, Chung, H C, Nagrial, A, Marabelle, A, Kelley, R K, Xu, L, Mahoney, J, Pruitt, S K, Oh, D-YVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.009
Date:
October, 2018
File:
PDF, 74 KB
english, 2018